Log In
BCIQ
Print this Print this
 

LYC-30937-EC

Also known as: LYC-30937

  Manage Alerts
Collapse Summary General Information
Company Lycera Corp.
DescriptionOral gut-directed ATPase modulator
Molecular Target
Mechanism of ActionATP production modulator
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

$5.0M


 Deals Details
Get a free BioCentury trial today